These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 12105241

  • 21. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 22. Long-term renal outcomes of IgA nephropathy presenting with different levels of proteinuria.
    Ai Z, Zhou Q, Huang F, Yang Q, Yu X.
    Clin Nephrol; 2020 Dec; 94(6):290-296. PubMed ID: 32990213
    [Abstract] [Full Text] [Related]

  • 23. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy.
    Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T.
    Nephron; 2002 Apr; 90(4):432-41. PubMed ID: 11961402
    [Abstract] [Full Text] [Related]

  • 24. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y, Wang Z, Guo W, Zhu L, Zhou X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2024 Jul 31; 39(8):1279-1287. PubMed ID: 38178632
    [Abstract] [Full Text] [Related]

  • 25. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG, de Almeida Araújo S, Bambirra EA, Oliveira EA, Simões E Silva AC, Pinheiro SVB.
    Pediatr Nephrol; 2017 Jul 31; 32(7):1211-1220. PubMed ID: 28233100
    [Abstract] [Full Text] [Related]

  • 26. Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy.
    Hwang JH, Lee JP, Kim CT, Yang SH, Kim JH, An JN, Moon KC, Lee H, Oh YK, Joo KW, Kim DK, Kim YS, Lim CS.
    Am J Nephrol; 2016 Jul 31; 44(6):481-492. PubMed ID: 27802442
    [Abstract] [Full Text] [Related]

  • 27. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.
    Am J Nephrol; 2015 Jul 31; 41(3):210-9. PubMed ID: 25872002
    [Abstract] [Full Text] [Related]

  • 28. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y, Tang X, Yang Y, Li X, Li L, Huang K, Li Y, Li J, Fu P.
    Ren Fail; 2020 Nov 31; 42(1):629-637. PubMed ID: 32660366
    [Abstract] [Full Text] [Related]

  • 29. First-year GFR slope and long-term renal outcome in IgA nephropathy.
    Lee K, Shin J, Park J, Hwang S, Jang HR, Huh W, Kwon GY, Kim YG, Oh HY, Lee JE, Kim DJ.
    Eur J Clin Invest; 2018 Jun 31; 48(6):e12936. PubMed ID: 29660832
    [Abstract] [Full Text] [Related]

  • 30. Cigarette smoking may accelerate the progression of IgA nephropathy.
    Wang S, Qin A, Pei G, Jiang Z, Dong L, Tan J, Tan L, Tang Y, Qin W.
    BMC Nephrol; 2021 Jun 29; 22(1):239. PubMed ID: 34187402
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF, Xie D, Wang J, Xu X, Yang X, Ai J, Nie S, Liang M, Wang G, Jia N, MAIN Trial Investigators.
    JAMA Netw Open; 2023 Feb 01; 6(2):e2254054. PubMed ID: 36745456
    [Abstract] [Full Text] [Related]

  • 32. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
    Sato Y, Tsukaguchi H, Higasa K, Kawata N, Inui K, Linh TNT, Quynh TTH, Yoshihiko I, Koiwa F, Yoshimura A.
    BMC Nephrol; 2021 Jun 19; 22(1):230. PubMed ID: 34147067
    [Abstract] [Full Text] [Related]

  • 33. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.
    Clin Exp Nephrol; 2016 Oct 19; 20(5):689-698. PubMed ID: 26564155
    [Abstract] [Full Text] [Related]

  • 34. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    Mohd R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, Wong YP, Shah SA, Alfian N.
    PLoS One; 2021 Oct 19; 16(4):e0249592. PubMed ID: 33831052
    [Abstract] [Full Text] [Related]

  • 35. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A, Iwabuchi Y, Nishida M, Uchida K, Nitta K.
    J Nephrol; 2015 Aug 19; 28(4):451-6. PubMed ID: 25355499
    [Abstract] [Full Text] [Related]

  • 36. The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.
    Xu X, Huang X, Chen Y, Li J, Shen M, Hou Y, Lin X, Lin Q, Liu X, Bao K, Wang L, Yang H, Liu L, Zou C.
    Int Urol Nephrol; 2022 Feb 19; 54(2):323-330. PubMed ID: 33871780
    [Abstract] [Full Text] [Related]

  • 37. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.
    Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y.
    Nephrol Dial Transplant; 2009 Oct 19; 24(10):3068-74. PubMed ID: 19515800
    [Abstract] [Full Text] [Related]

  • 38. Clinical significance of mesangial IgM deposition in patients with IgA nephropathy.
    Heybeli C, Oktan MA, Yıldız S, Arda HÜ, Ünlü M, Çavdar C, Sifil A, Çelik A, Sarıoğlu S, Çamsarı T.
    Clin Exp Nephrol; 2019 Mar 19; 23(3):371-379. PubMed ID: 30293216
    [Abstract] [Full Text] [Related]

  • 39. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
    Tanaka S, Ninomiya T, Masutani K, Nagata M, Tsuchimoto A, Tsuruya K, Kitazono T.
    Clin Exp Nephrol; 2015 Dec 19; 19(6):1062-70. PubMed ID: 25700934
    [Abstract] [Full Text] [Related]

  • 40. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H.
    Am J Kidney Dis; 2020 Jul 19; 76(1):90-99. PubMed ID: 32197881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.